TCL Archive Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation April 28, 2006
TCL Archive Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention October 14, 1994
TCL Archive In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs November 27, 1998
TCL Archive Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma September 5, 2014